Drug class
First-generation piperazine antihistamine; H1 receptor antagonist with antiemetic activity
Mechanism of action
Antagonises central histamine H1 receptors and has anticholinergic activity, reducing vestibular stimulation and signalling in emetic pathways.
General use cases
- Prevention and treatment of nausea, vomiting and motion sickness
- Treatment of nausea and vomiting associated with vertigo or other vestibular disorders; formulation and indication are jurisdiction-specific
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
